Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.

Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kaufman B, Garber JE, Merajver SD, Balmaña J, Meirovitz A, Domchek SM.

Breast Cancer Res Treat. 2010 Jun;121(2):389-98. doi: 10.1007/s10549-010-0894-z.

2.

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.

Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A.

Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Review.

PMID:
20033769
3.

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.

Valachis A, Nearchou AD, Lind P.

Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Review.

PMID:
24567198
4.

BRCA1/2 Mutation-associated Breast Cancer, Wide Local Excision and Radiotherapy or Unilateral Mastectomy: A Systematic Review.

Hallam S, Govindarajulu S, Huckett B, Bahl A.

Clin Oncol (R Coll Radiol). 2015 Sep;27(9):527-35. doi: 10.1016/j.clon.2015.06.001. Review.

PMID:
26113392
5.

Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.

Yao K, Liederbach E, Tang R, Lei L, Czechura T, Sisco M, Howard M, Hulick PJ, Weissman S, Winchester DJ, Coopey SB, Smith BL.

Ann Surg Oncol. 2015 Feb;22(2):370-6. doi: 10.1245/s10434-014-3883-3. Review. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4:S788. Weissman, Scott [added].

PMID:
25023546
6.

Who should not undergo breast conservation?

Nijenhuis MV, Rutgers EJ.

Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021. Review.

PMID:
24074770
7.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

8.

Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.

Pierce L.

Semin Radiat Oncol. 2002 Oct;12(4):352-61. Review.

PMID:
12382193
9.

Factors increasing local recurrence in breast-conserving surgery.

Fatouros M, Roukos DH, Arampatzis I, Sotiriadis A, Paraskevaidis E, Kappas AM.

Expert Rev Anticancer Ther. 2005 Aug;5(4):737-45. Review.

PMID:
16111473
10.

The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.

van Nes JG, van de Velde CJ.

Breast. 2006 Dec;15 Suppl 2:S3-10. Review. Erratum in: Breast. 2008 Apr;17(2):213.

PMID:
17382859
11.

Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer.

Phillips KA, McKay MJ.

Australas Radiol. 2001 May;45(2):200-4. Review.

PMID:
11380364
12.

Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.

Drooger JC, Hooning MJ, Seynaeve CM, Baaijens MH, Obdeijn IM, Sleijfer S, Jager A.

Cancer Treat Rev. 2015 Feb;41(2):187-96. doi: 10.1016/j.ctrv.2014.12.002. Review.

PMID:
25533736
13.

Breast cancer multifocality and multicentricity and locoregional recurrence.

Lynch SP, Lei X, Hsu L, Meric-Bernstam F, Buchholz TA, Zhang H, Hortobágyi GN, Gonzalez-Angulo AM, Valero V.

Oncologist. 2013;18(11):1167-73. doi: 10.1634/theoncologist.2013-0167. Review.

14.

[Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

Nestle-Krämling C, Bölke E, Budach W, Peiper M, Niederacher D, Janni W, Eisenberger CF, Knoefel WT, Scherer A, Baldus SE, Lammering G, Gerber PA, Matuschek C.

Strahlenther Onkol. 2011 Oct;187(10):656-64. doi: 10.1007/s00066-011-2251-5. Review. German.

PMID:
21858416
15.

Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.

Eccles DM, Simmonds P, Goddard J, Coultas M, Lalloo F, Evans G, Haites N.

Dis Markers. 1999 Oct;15(1-3):187-9. Review. No abstract available.

16.

Contralateral risk reducing mastectomy in patients with sporadic breast cancer. Benefits and hazards.

Boccardo C, Gentilini O.

Eur J Surg Oncol. 2016 Jul;42(7):913-8. doi: 10.1016/j.ejso.2016.04.054. Review.

PMID:
27189832
Items per page

Supplemental Content

Support Center